Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
Science 37 Holdings, Inc. (Nasdaq: SNCE) will release its third quarter 2022 financial results on November 10, 2022, after market close. A conference call for investors is scheduled for November 11, 2022, at 8:30 a.m. ET. Interested participants must register in advance to obtain dial-in details. Following the call, a replay will be available for 90 days. Science 37 aims to enhance clinical research accessibility, utilizing a technology platform that enables faster enrollment and better retention in decentralized clinical trials.
- Science 37's technology allows up to 21x faster enrollment in clinical trials.
- The company supports 28% better retention of trial participants.
- None.
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022. Company management will host a corresponding conference call on Friday, November 11, 2022, at 8:30 a.m. Eastern Time.
The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://investors.science37.com/news-events/events-presentations. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes before the start of the call to obtain a unique pin for the call.
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full-stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment,
Contacts:
MEDIA INQUIRIES:
Drew Bustos
Science 37
Phone: (610) 417-6953
Email: pr@science37.com
INVESTOR RELATIONS:
Steve Halper
Managing Director
LifeSci Advisors
Phone: (646) 876-6455
Email: shalper@lifesciadvisors.com
FAQ
When will Science 37 report its Q3 2022 financial results?
What time is the Science 37 conference call for Q3 2022 results?
How can I access the Science 37 Q3 2022 financial results conference call?